These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

894 related items for PubMed ID: 27769634

  • 1. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
    Nos C, Clough KB, Bonnier P, Lasry S, Le Bouedec G, Flipo B, Classe JM, Missana MC, Doridot V, Giard S, Charitansky H, Charles-Nelson A, Bats AS, Ngo C.
    Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
    [Abstract] [Full Text] [Related]

  • 2. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
    Tummel E, Ochoa D, Korourian S, Betzold R, Adkins L, McCarthy M, Hung S, Kalkwarf K, Gallagher K, Lee JY, Klimberg VS.
    Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
    [Abstract] [Full Text] [Related]

  • 3. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, Rageth C.
    Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
    [Abstract] [Full Text] [Related]

  • 4. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
    Beek MA, Gobardhan PD, Klompenhouwer EG, Rutten HJ, Voogd AC, Luiten EJ.
    Eur J Surg Oncol; 2015 Jan; 41(1):59-63. PubMed ID: 25468747
    [Abstract] [Full Text] [Related]

  • 5. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S, Wang N, Gao P, Liu P, Yang H, Xie F, Wang S, Liu M, Wang S.
    World J Surg Oncol; 2020 Jun 01; 18(1):118. PubMed ID: 32482174
    [Abstract] [Full Text] [Related]

  • 6. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
    Khandelwal R, Poovamma CU, Shilpy C, Prema M, Anthony P.
    Breast Dis; 2014 Jan 01; 34(4):151-5. PubMed ID: 24934169
    [Abstract] [Full Text] [Related]

  • 7. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
    Noguchi M, Inokuchi M, Noguchi M, Morioka E, Kurita T.
    Eur J Surg Oncol; 2020 Dec 01; 46(12):2218-2220. PubMed ID: 32912671
    [Abstract] [Full Text] [Related]

  • 8. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B, Yuruker S, Sullu Y, Gursel B, Ozen N.
    J Invest Surg; 2019 Jan 01; 32(1):48-54. PubMed ID: 28945489
    [Abstract] [Full Text] [Related]

  • 9. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G.
    Orv Hetil; 2013 Dec 08; 154(49):1934-42. PubMed ID: 24292111
    [Abstract] [Full Text] [Related]

  • 10. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K, Ogawa Y, Kajino C, Deguchi S, Kurihara S, Tashima T, Goto W, Nishiguchi Y, Tokunaga S, Fukushima H, Inoue T.
    Eur J Surg Oncol; 2014 Jul 08; 40(7):818-23. PubMed ID: 24768416
    [Abstract] [Full Text] [Related]

  • 11. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Beek MA, Gobardhan PD, Klompenhouwer EG, Menke-Pluijmers MB, Steenvoorde P, Merkus JW, Rutten HJ, Voogd AC, Luiten EJ.
    Eur J Surg Oncol; 2020 Jan 08; 46(1):59-64. PubMed ID: 31402072
    [Abstract] [Full Text] [Related]

  • 12. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J, Jia S, Zhang W, Qiu F, Zhang Y, Gu X, Xue J.
    BMC Surg; 2015 Jun 30; 15():79. PubMed ID: 26123412
    [Abstract] [Full Text] [Related]

  • 13. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
    Parks RM, Cheung KL.
    Breast; 2017 Jun 30; 33():57-70. PubMed ID: 28282588
    [Abstract] [Full Text] [Related]

  • 14. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
    Seyednejad N, Kuusk U, Wiseman SM.
    Expert Rev Anticancer Ther; 2014 Jul 30; 14(7):771-81. PubMed ID: 24621187
    [Abstract] [Full Text] [Related]

  • 15. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF.
    Dan Med J; 2017 Oct 30; 64(10):. PubMed ID: 28975889
    [Abstract] [Full Text] [Related]

  • 16. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.
    Noguchi M, Noguchi M, Ohno Y, Morioka E, Nakano Y, Kosaka T, Kurose N, Minato H.
    Eur J Surg Oncol; 2016 May 30; 42(5):650-6. PubMed ID: 27005806
    [Abstract] [Full Text] [Related]

  • 17. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
    Wijaya WA, Peng J, He Y, Chen J, Cen Y.
    Breast; 2020 Oct 30; 53():189-200. PubMed ID: 32858404
    [Abstract] [Full Text] [Related]

  • 18. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H, Hunt C, Bharat C, Murray K, Kamyab R, Saunders C.
    ANZ J Surg; 2018 Sep 30; 88(9):917-921. PubMed ID: 29392828
    [Abstract] [Full Text] [Related]

  • 19. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
    Klompenhouwer EG, Gobardhan PD, Beek MA, Voogd AC, Luiten EJ.
    Trials; 2013 Apr 25; 14():111. PubMed ID: 23782712
    [Abstract] [Full Text] [Related]

  • 20. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
    Connor C, McGinness M, Mammen J, Ranallo L, Lafaver S, Klemp J, Fan F, Mahnken J.
    Ann Surg Oncol; 2013 Oct 25; 20(10):3303-7. PubMed ID: 23975287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.